Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: Toxins, mediators, and modulators of gene expression

Inflammatory Bowel Diseases

Volumn 2, Issue 2, 1996, Pages 133-147

  Conner, Elaine M ^a   Brand, Stephen J ^b   Davis, Jonathan M ^a   Kang, David Y ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b ProScript   (United States)

Author keywords

Gene expression; Inflammatory bowel disease; Nitrogen; Oxygen; Reactive species

Indexed keywords

EID: 0001010783     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020211     Document Type: Review

References (111)

1. Riddell RH. Pathology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Baltimore: Williams & Wilkins, 1995:517-54.
2. Yamada T, Grisham MB. Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams & Wilkins, 1994: 133-50.
3. Klebanoff SJ. In: Oxygen metabolites from phagocytes. Inflammation-basic principles and clinical correlates. Gallin JI, Goldstein IM, Snyderman R, eds. New York: Raven Press, 1992:541-88.
4. Sies H. Oxidative stress. London: Academic Press, 1985: 1-8.
5. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859-61.
6. Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence, or epiphenomenon? Pharmacol Ther 1992;53:375-408.
7. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radical Biol 1992;13:169-81.
8. Laursen LS, Naesdal J, Bukhave K, Lauritsen K, Rask-Madsen J. Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet 1990;335:683-5.
9. Wallace JL, Higa A, McKnignt GW, MacIntyre DE. Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence. Inflammation 1990;10:1-12.
10. Domek MJ, Iwata F, Blackman El, et al. Anti-neutrophil serum attenuates dextran sulfate sodium-induced colonic damage in the rat. Scand J Gastroenterol 1995;30:1089-94.
11. Chen Y, Conner EM, Grisham MB. Role of neutrophils in DSS-induced colitis in rats [Abstract]. Gastroenterology (in press).
12. Grisham MB. In: Reactive oxygen metabolites of oxygen and nitrogen in biology and medicine. Austin: Landes, 1992.
13. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
14. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-50.
15. Rubbo H, Radi R, Trujillo M, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994;269:26066-75.
16. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-7.
17. King PA, Jamison E, Strahs D, Anderson VE, Brenowitz M. "Footprinting" proteins on DNA with peroxynitrous acid. Nucleic Acids Res 1993;21:2473-8.
18. Zhu L, Gunn C, Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys 1992;298:452-7.
19. Kooy NW, Royall JA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys 1994;310:352-9.
20. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298:446-51.
21. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1992;264:11-6.
22. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric synthesis in ulcerative colitis. Lancet 1993;341:465-6.
23. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB. Mucosal injury and inflammation in a model of granulomatous colitis in rats. Gastroenterology 1993;104:759-77.
24. Boughton-Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993;342:338-40.
25. Grisham MB, Specian RD, Zimmerman TE. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 1994;271:1114-21.
26. Aiko S, Grisham MB. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 1995;109:142-50.
27. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
28. Pollock JS, Forstermann U, Tracey WR, Nakane M. Nitric oxide synthase isozyme antibodies. Histochem J 1995;27: 738-44.
29. Miles AM, Owens MW, Milligan S, et al. Nitric oxide synthase in circulating vs extravasated polymorphonuclear leukocytes. J Leukocyte Biol 1995;58:616-22.
30. Weinberg JB, Misukonis MA, Shami PJ, et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995;86:1184-95.
31. Kim Y, Bergonia HA, Muller C, Pitt BR, Watkins WD, Lancaster JR. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem 1995;270:5710-3.
32. Gaginella TS, Kachur JF, Tamai H, Keshavarzian A. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. Gastroenterology 1995;109:2019-28.
33. Winterbourn CC, van den Berg JJM, Roitman E, Kuypers FA. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch Biochem Biophys 1992;296:547-55.
34. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
35. Grisham MB, Gaginella TS, von Ritter C, Tamai H, Be RM, Granger DN. Effects of neutrophil-derived oxidants on intestinal permeability. Electrolyte transport, and epithelial cell viability. Inflammation 1990;14:531-42.
36. Tamai H, Gaginella TS, Kachur JF, Musch MW, Chang EB. Ca-mediated stimulation of Cl secretion by reactive oxygen metabolites in human colonic T84 cells. J Clin Invest 1991;89:301-7.
37. 2Cl-induced rat colonic electrolyte secretion. Am J Physiol 1993;265:C166-70.
38. Tamai H, Kachur J, Baron DA, Grisham MB, Gaginella TS. Monochloramine, a neutrophil-derived oxidant, stimulates rat colonic secretion. J Pharmacol Exp Ther 1991;257: 887-94.
39. Gaginella TS, Grisham MB, Thomas DB, Walsh R, Moummi C. Oxidant-evoked release of acetylcholine from enteric neurons of the rat colon. J Pharmacol Exp Ther 1992;263:1068-73.
40. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990;76:655-63.
41. Thomas EL, Jefferson MM, Bennett JJ, Learn DB. Mutagenic activity of chloramines. Mutat Res 1987;188:35-43.
42. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001.
43. Nguyen T, Brunson D, Crespit C, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030-4.
44. Grisham MB, Yamada T. Neutrophils, nitrogen oxides, and inflammatory bowel disease. Ann NY Acad Sci 1992;664: 103-10.
45. Baeuerle PA, Henkle T. Function and activation of NF-kB in the immune system. Annu Rev Immunol 1994;12:141-79.
46. Kopp E, Ghosh S. NF-kB and Rel proteins in innate immunity. Adv Immunol 1994;58:1-27.
47. Baeuerle PA, Baltimore D. IkB: a specific inhibitor of the NF-kB transcription factor. Science 1988;242:540-6.
48. Goldberg AL. Functions of the proteasome: the lysis at the end of the tunnel. Science 1995;268:522-3.
49. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994;79:13-21.
50. Beg AA, Finco TS, Nantermet PV, Baldwin AS. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkB: a mechanism for NF-kB activation. Mol Cell Biol 1993;13:3301-10.
51. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of IkB-α proteolysis by site-specific, signal induced phosphorylation. Science 1995;267:1485-8.
52. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kBl precursor protein and the activation of NF-kB. Cell 1994;78:773-85.
53. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-kB transcription factor and HlV-1. EMBO J 1991;10:2247-58.
54. Shibanuma M, Kuroki T, Nose K. Inhibition by N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF-kB by tumor necrosis factor-α in a mouse fibroblastic cell line, Balb/3T3. FEBS Lett 1994;353:62-6.
55. Suzuki YJ, Packer L. Inhibition of NF-kB by vitamin E derivatives. Biochem Biophys Res Commun 1993;193:277-83.
56. Suzuki YJ, Aggarwal BB, Packer L. α-Lipoic acid is a potent inhibitor of NF-kB activation in human T cells. Biochem Biophys Res Commun 1992;189:1709-15.
57. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kB activation in intact cells. J Exp Med 1992;175:11810.
58. Osborn L, Kunkel S, Nabel GJ. TNF-α and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the NF-kB. Proc Natl Acad Sci USA 1989;86: 2336-40.
59. Iwasaki T, Uehara Y, Graves L, Rachie N, Bomsztyk K. Herbimycin A blocks IL-1 induced NF-kB DNA-binding activity in lymphoid cell lines. FEBS Lett 1992;298:240-4.
60. Schreck R, Albermann K, Baeuerle PA. NF-kB: an oxidative stress-responsive transcription factor of eukaryotic cells [Review]. Free Radical Res Commun 1992;17:221-37.
61. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993;187:233-56.
62. Shakhov AN, Collart MA, Vassilli P, Nedospasov SA, Jongeneel CV. kB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of tumor necrosis factor α gene in primary macrophages. J Exp Med 1990; 171:35-47.
63. Hoyos B, Ballard DW, Bohnlein E, Siekevity M, Greene WC. Kappa-B specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 1989;244:457-60.
64. Lieberman TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kB transcription factor. Mol Cell Biol 1990;10:2327-34.
65. Adcock IM, Brown CR, Kwon O, Barnes PJ. Oxidative stress induced NF-kB binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994;199:1518-24.
66. Chen CC, Manning AM. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa-B. Agents Actions [Suppl] 1995;47:135-41.
67. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T. Endothelial IRF-1 cooperates with NF-kB as a transcriptional activator of vascular cell adhesion molecule-1. Mol Cell Biol 1995;19:2558-69.
68. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995;2:493-506.
69. Conner EM, Brand S, Grisham MB. Inhibition of chronic granulomatous colitis by a selective proteasome inhibitor: antagonist of nuclear transcription factor kB (NFkB) activation. [Abstract] Gastroenterology (in press).
70. Keshavarzian A, Sedghi S, Kanofsky J, et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992;103:177-85.
71. Simmonds NJ, Allen RE, Stevens TRJ, et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992;103: 186-96.
72. Hauser CL, Locke RR, Kao HW, Patterson J, Zipser RD. Visceral surface oxygen tension in experimental colitis in the rabbit. J Lab Clin Med 1988;112:68-71.
73. Oshitani N, Kitano A, Okabe H, Nakamura S, Matsumato T, Kobayashi K. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut 1993;34: 936-8.
74. Grisham MB, MacDermott RP, Deitch EA. Oxidant defense mechanisms in the human colon. Inflammation 1990; 14:669-80.
75. Mulder TPJ, Verspaget HW, Janssens AR, de Bruin PAF, Pena AS, Lamers CBHW. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991;32:1146-50.
76. Buffinton GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radicals Biol Med 1995;19:991-8.
77. Ahnfelt-Ronne I, Neilson OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990;98:1162-9.
78. McKenzie SJ, Buffinton GD, Baker MS, Doe WF. Colonic epithelial cell glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a target of oxidative injury in inflammatory bowel disease (IBD). Gastroenterology 1993;104:A741.
79. Schraufstatter IU, Browne K, Harris A, et al. Mechanisms of hypochlorite injury of target cells. J Clin Invest 1990;85: 554-62.
80. Lundberg JON, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673-1.
81. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718-23.
82. Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 1995;268:G673-84.
83. Aiko S, Grisham MB. Effects of NOS inhibition and sulfasalazine on the spontaneous intestinal inflammation observed in HLA-B27 transgenic rats [Abstract]. Gastroenterology (in press).
84. Sartor RB. Cytokines in intestinal inflammation: pathophysiology and clinical considerations. Gastroenterology 1994;106:533-7.
85. Grisham MB. Nitric oxide production by intestinal epithelial. Gastroenteralogy 1993;104:A710.
86. Tepperman BL, Brown JF, Whittle BJR. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993;265:G214-8.
87. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989;169:1543-55.
88. Granger DL, Hibbs JB, Perfect JF, Durack DT. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest 1990;85:264-73.
89. Kroncke KD, Brenner HH, Rodriguez ML, et al. Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. Biochem Biophys Acta 1993;1182:221-9.
90. Kroncke KD, Rodriquez ML, Kolb H, Kolb-Bachofen V. Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside. Diabetologia 1993;36: 17-24.
91. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991;260:C910-6.
92. Albina JE, Abate JA, Henry WL. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T-cell proliferation: role of IFN-γ in the induction of the nitric oxide synthesizing pathway. J Immunol 1991;147:144-8.
93. G-monomethyl-L-arginine: a role for cyclic GMP: Blood 1989;74: 1885-7.
94. Belenky SN, Robbins RA, Rennard SI, Gossman GL, Nelson KJ, Rubinstein I. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 1993;122:388-94.
95. Belenky SN, Robbins RA, Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukocyte Biol 1993;53:498-503.
96. Villarete LH, Remick DG. Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem Biophys Res Commun 1995;211:671-6.
97. Granger DL, Taintor RR, Cook JL, Hibbs JB. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest 1980;65:357-70.
98. Hibbs JB, Taintor RR, Vavrin Z. Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun 1984;123:716-23.
99. Kwon NS, Stuehr DJD, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991;174:761-7.
100. Emerit J, Pelletier S, Tosoni-Verilgnue D, Mollet M. Phase II trial of copper/zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease. Free Radicals Biol Med 1989; 7:145-9.
101. Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut 1990;31:786-90.
102. 4 decrease experimental colitis. Dig Dis Sci 1992;37:1866-73.
103. Grisham MB, Granger DN. 5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine. Dig Dis Sci 1989;34:575-8.
104. Miles AM, Grisham MB. Antioxidant properties of aminosalicylates. Methods Enzymol 1994;234:555-72.
105. Hoult JRS, Page H. 5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis? Lancet 1981;2:255.
106. Fedorak RN, Empey LR, MacArthur C, Jewell ID. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology 1990; 98:615-25.
107. Yamada T, Fujimoto K, Tso P, Fujimoto T, Gaginella TS, Grisham MB. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis. J Pharmacol Exp Ther 1992;260:313-8.
108. Grisham MB, Miles AM. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. Biochem Pharmacol 1994;47:1897-902.
109. Miles AM, Gibson MF, Kirshna M, et al. Effects of superoxide on nitric oxide-dependent N-nitrosation reactions. Free Radical Res 1995;23:379-90.
110. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996;271:40-7.
111. Aiko S, Benoit JN, Davis JM, Grisham MB. Effect of acute and chronic NOS inhibition on splanchnic organ blood flow: implications in gut and liver pathophysiology. Gastroenterology 1995;108:A268.